<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Bruining, H.A.</title>
    <link>http://repub.eur.nl/res/aut/318/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Prospective study of the performance of vibrational spectroscopies for rapid identification of bacterial and fungal pathogens recovered from blood cultures (Article)</title>
      <link>http://repub.eur.nl/res/pub/10046/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Rapid identification of microbial pathogens reduces infection-related
      morbidity and mortality of hospitalized patients. Raman spectra and
      Fourier transform infrared (IR) spectra constitute highly specific
      spectroscopic fingerprints of microorganisms by which they can be
      identified. Little biomass is required, so that spectra of microcolonies
      can be obtained. A prospective clinical study was carried out in which the
      causative pathogens of bloodstream infections in hospitalized patients
      were identified. Reference libraries of Raman and IR spectra of bacterial
      and yeast pathogens highly prevalent in bloodstream infections were
      created. They were used to develop identification models based on linear
      discriminant analysis and artificial neural networks. These models were
      tested by carrying out vibrational spectroscopic identification in
      parallel with routine diagnostic phenotypic identification. Whereas
      routine identification has a typical turnaround time of 1 to 2 days, Raman
      and IR spectra of microcolonies were collected 6 to 8 h after microbial
      growth was detected by an automated blood culture system. One hundred
      fifteen samples were analyzed by Raman spectroscopy, of which 109
      contained bacteria and 6 contained yeasts. One hundred twenty-one samples
      were analyzed by IR spectroscopy. Of these, 114 yielded bacteria and 7
      were positive for yeasts. High identification accuracy was achieved in
      both the Raman (92.2%, 106 of 115) and IR (98.3%, 119 of 121) studies.
      Vibrational spectroscopic techniques enable simple, rapid, and accurate
      microbial identification. These advantages can be easily transferred to
      other applications in diagnostic microbiology, e.g., to accelerate
      identification of fastidious microorganisms.</description>
    </item> <item>
      <title>Monitoring the penetration enhancer dimethyl sulfoxide (Article)</title>
      <link>http://repub.eur.nl/res/pub/10880/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>The stratum corneum (SC) barrier typically consists of
layers of corneocytes embedded in a lipid continuum that
regulates barrier function. The lipid domain containing ceramides,
cholesterol, and free fatty acids provides the major
pathway for most drugs permeating across SC (1).
Penetration enhancers diminish the SC barrier function.
The classic enhancer is dimethyl sulfoxide (DMSO) (2). Its
mechanisms of action remain unclear, although DMSO disrupts
lipid organisation and may displace protein-bound water
(3).
Here we use confocal Raman spectroscopy to probe molecular
interactions between a finite (depleting) dose of
DMSO and SC, as functions of depth and time, providing
novel information about residence time and location of
DMSO in human SC in vivo.</description>
    </item> <item>
      <title>Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections (Article)</title>
      <link>http://repub.eur.nl/res/pub/9811/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>Ceftazidime demonstrates time-dependent killing, which is maximal at 4 x
      or 5 x MIC for the organism, consequently continuous infusion (CI) has
      been proposed to ensure adequate ceftazidime concentrations for the entire
      course of therapy. Severe intra-abdominal infections (IAIs) require
      surgical or percutaneous drainage for management, and ceftazidime is
      frequently prescribed. Cardiovascular or metabolic changes and renal or
      liver dysfunction may alter drug pharmacokinetics during severe IAIs, and
      no data exist on concentrations of ceftazidime reached in the peritoneal
      fluid. The objectives here were to determine the pharmacokinetics of
      ceftazidime during continuous and intermittent administration in patients
      with severe IAIs, and to measure the concentrations of ceftazidime in the
      peritoneal exudate. Eighteen surgical patients with severe IAI and a
      creatinine clearance of &gt;30 mL/min were studied. A non-randomized pilot
      study of six patients treated with CI alone was followed by a prospective,
      randomized comparative study of 12 patients. Pilot study patients received
      ceftazidime 1 g iv followed by a 4.5 g CI over 24 h. Randomized patients
      received either ceftazidime continuously as above or 1.5 g tds. Samples
      for pharmacokinetic analyses were collected on days 2 and 4. Ceftazidime
      concentrations were determined by high-performance liquid chromatography.
      CI resulted in a mean serum concentration &gt;40 mg/L and a T&gt; 4 x MIC for
      most pathogens encountered in severe IAIs for &gt;90% of the course of
      therapy in both serum and peritoneal exudate. Eight-hourly administration
      resulted in T&gt; 4 x MIC for most pathogens encountered in severe IAIs for
          &gt;90% of the dosing interval, but in peritoneal exudate for only 44% of the
      dosing interval. During CI, AUCs in the peritoneal exudate were c. 60% of
      the concomitant serum AUCs. In critically ill surgical patients with
      severe IAIs, CI of ceftazidime resulted in more favourable concentrations
      in serum and peritoneal exudate than 8-hourly bolus infusion.</description>
    </item> <item>
      <title>Rapid identification of Candida species by confocal Raman microspectroscopy (Article)</title>
      <link>http://repub.eur.nl/res/pub/9833/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>Candida species are important nosocomial pathogens associated with high
      mortality rates. Rapid detection and identification of Candida species can
      guide a clinician at an early stage to prescribe antifungal drugs or to
      adjust empirical therapy when resistant species are isolated. Confocal
      Raman microspectroscopy is highly suitable for the rapid identification of
      Candida species, since Raman spectra can be directly obtained from
      microcolonies on a solid culture medium after only 6 h of culturing. In
      this study, we have used a set of 42 Candida strains comprising five
      species that are frequently encountered in clinical microbiology to test
      the feasibility of the technique for the rapid identification of Candida
      species. The procedure was started either from a culture on Sabouraud
      medium or from a positive vial of an automated blood culture system. Prior
      to Raman measurements, strains were subcultured on Sabouraud medium for 6
      h to form microcolonies. Using multivariate statistical analyses, a high
      prediction accuracy (97 to 100%) was obtained with the Raman method.
      Identification with Raman microspectroscopy may therefore be significantly
      faster than identification with commercial identification systems that
      allow various species to be identified and that often require 24 to 48 h
      before a reliable identification is obtained. We conclude that confocal
      Raman microspectroscopy offers a rapid, accurate, and easy-to-use
      alternative for the identification of clinically relevant Candida species.</description>
    </item> <item>
      <title>The value of plasma markers for the clinical behaviour of phaeochromocytomas (Article)</title>
      <link>http://repub.eur.nl/res/pub/9928/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: Phaeochromocytomas (PCCs) are widely known for their clinical
      unpredictability. This study intends to define predictive plasma markers
      for their variable postoperative behaviour. Furthermore, the diagnostic
      accuracy of these plasma tests was determined. DESIGN AND METHODS: A
      retrospective correlative study was performed in a series of 83 operated
      and four autopsied patients in order to correlate preoperative
      catecholamine (CAT) levels of 103 PCCs with their clinical behaviour. In a
      subset of cases, chromogranin-A (Chr-A) and enzymes/precursors of the CAT
      biosynthesis were studied for their predictive value. RESULTS: Basal CAT
      levels were elevated in 81/87 instances (sensitivity: 93%). Four of six
      cases with normal measurements showed only medullary hyperplasia. Larger
      PCCs, particularly those showing necrosis, capsular and vascular invasion,
      secreted higher CAT levels. Bilateral, hereditary tumours were less
      productive than their unilateral counterparts. Extra-adrenal PCCs secreted
      significantly lower levels of epinephrine (EPI) than intra-adrenal
      tumours. Fourteen patients developed metastases. According to Kaplan-Meier
      estimations, patients with higher levels of dopamine, norepinephrine (NE)
      and aromatic l-amino acid decarboxylase as well as lower ratios of
      EPI/EPI+NE, had significantly shorter metastases-free intervals. Existence
      of preoperative hypertension, left ventricular hypertrophy and measured
      blood pressures showed significant positive relationships with CAT levels,
      but not with Chr-A. CONCLUSIONS: These data showed that plasma CAT
      measurement is a sensitive method in the diagnostic work-up of PCCs. Those
      tumours producing normal levels are commonly small and asymptomatic.
      Furthermore, certain secretion patterns are indicative of the presence of
      metastases as well as the size and site of sporadic and syndrome-related
      PCCs.</description>
    </item> <item>
      <title>Investigating microbial (micro)colony heterogeneity by vibrational spectroscopy. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12922/</link>
      <pubDate>2001-04-01T00:00:00Z</pubDate>
      <description>Fourier transform infrared and Raman microspectroscopy are currently being
          developed as new methods for the rapid identification of clinically
          relevant microorganisms. These methods involve measuring spectra from
          microcolonies which have been cultured for as little as 6 h, followed by
          the nonsubjective identification of microorganisms through the use of
          multivariate statistical analyses. To examine the biological heterogeneity
          of microorganism growth which is reflected in the spectra, measurements
          were acquired from various positions within (micro)colonies cultured for
          6, 12, and 24 h. The studies reveal that there is little spectral variance
          in 6-h microcolonies. In contrast, the 12- and 24-h cultures exhibited a
          significant amount of heterogeneity. Hierarchical cluster analysis of the
          spectra from the various positions and depths reveals the presence of
          different layers in the colonies. Further analysis indicates that spectra
          acquired from the surface of the colonies exhibit higher levels of
          glycogen than do the deeper layers of the colony. Additionally, the

          spectra from the deeper layers present with higher RNA levels than the
          surface layers. Therefore, the 6-h colonies with their limited
          heterogeneity are more suitable for inclusion in a spectral database to be
          used for classification purposes. These results also demonstrate that
          vibrational spectroscopic techniques can be useful tools for studying the
          nature of colony development and biofilm formation.</description>
    </item> <item>
      <title>In vivo confocal Raman microspectroscopy of the skin: Noninvasive determination of molecular concentration profiles (Article)</title>
      <link>http://repub.eur.nl/res/pub/10881/</link>
      <pubDate>2001-03-20T00:00:00Z</pubDate>
      <description>Confocal Raman spectroscopy is introduced as a noninvasive in vivo optical method to measure molecular concentration profiles in the skin. It is shown how it can be applied to determine the water concentration in the stratum corneum as a function of distance to the skin surface, with a depth resolution of 5 mum. The resulting in vivo concentration profiles are in qualitative and quantitative agreement with published data, obtained by in vitro X-ray microanalysis of skin samples. Semi-quantitative concentration profiles were determined for the major constituents of natural moisturizing factor (serine, glycine, pyrrolidone-5-carboxylic acid, arginine, ornithine, citrulline, alanine, histidine, urocanic acid) and for the sweat constituents lactate and urea. A detailed description is given of the signal analysis methodology that enables the extraction of this information from the skin Raman spectra. No other noninvasive in vivo method exists that enables an analysis of skin molecular composition as a function of distance to the skin surface with similar detail and spatial resolution. Therefore, it may be expected that in vivo confocal Raman spectroscopy will find many applications in basic and applied dermatologic research.</description>
    </item> <item>
      <title>Fertility and body composition after laparoscopic bilateral adrenalectomy in a 30-year-old female with congenital adrenal hyperplasia (Article)</title>
      <link>http://repub.eur.nl/res/pub/9572/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is caused
          by an inborn defect in the 21-hydroxylase gene (CYP21), leading to
          virilization of female patients and causing ambiguous genitals in the
          majority of female infants. Adult women may suffer from loss of libido,
          irregular or absent cycles, and reduced fertility, despite intensive
          medical treatment. These problems have stimulated the search for
          alternative treatment modalities. We present an adult female patient, who
          was difficult to treat medically and whose clinical situation markedly
          improved after laparoscopic bilateral adrenalectomy. The procedure was
          well tolerated and without side effects. Postoperatively the elevated
          serum progesterone and 17-hydroxyprogesterone levels, as well as the
          undetectable LH levels, normalized. The procedure resulted in marked
          clinical improvement. Within 12 months after surgery she lost 11 kg in
          weight. This weight loss consisted mainly of adipose tissue. Acne
          disappeared, and she had a regular 4-week menstrual cycle, with
          progesterone levels that are compatible with a luteal phase. The
          introduction of laparoscopic techniques may give an impulse to the
          application of surgical therapy at a larger scale in patients with
          21-hydroxylase deficiency who are difficult to treat with adrenal
          suppression therapy.</description>
    </item> <item>
      <title>[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas (Article)</title>
      <link>http://repub.eur.nl/res/pub/9575/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Selecting the appropriate approach for resection and follow-up of
          pheochromocytomas (PCCs) is highly dependent upon reliable localization
          and exclusion of multifocal, bilateral, or metastatic disease.
          Metaiodobenzylguanidine (MIBG) scintigraphy was developed for functional
          localization of catecholamine-secreting tissues. Somatostatin receptor
          imaging (SRI) has a high sensitivity for localizing head and neck
          paragangliomas, but studies of intraabdominal PCCs are rare. In this study
          we review our experience of [(123)I]MIBG and SRI, performed since 1983 and
          1989, respectively, in the work-up of primary and recurrent PCCs.
          Scintigraphic results were correlated with catecholamine secretion, size
          and site, malignancy, associated tumor syndromes, and morphological
          features. [(123)I]MIBG scans were performed in a total of 75 patients, in
          70 cases before resection of primary PCCs and in 5 cases because of
          recurrent disease. Ninety-one PCCs were resected. The overall detection
          rates were 83.3% and 89.8% for PCCs larger than 1.0 cm. Multifocal disease
          was detected in 4 patients with [(123)I]MIBG. [(123)I]MIBG uptake
          correlated with greater size of PCC (r = 0.33; P = 0.008) and greater
          concentration of plasma epinephrine (r = 0.32; P = 0.006).
          [(123)I]MIBG-negative PCCs (n = 14) had significantly (P = 0.01) smaller
          diameters than [(123I)]MIBG-positive tumors. Furthermore, [(123)I]MIBG
          uptake was significantly higher in unilateral (P = 0.02), benign (P =
          0.02), sporadic (P = 0.02), intraadrenal (P = 0.02), and capsular invasive
          (P = 0.03) PCCs than in bilateral, malignant, MEN2A/2B-related,
          extraadrenal, and noninvasive PCCs, respectively. The detection rate of
          SRI was only 25% (8 of 32) for primary benign PCCs. In 14 patients
          metastases occurred, which were effectively visualized with [(123)I]MIBG
          in 8 of 14 cases. SRI was able to detect metastases in 7 of 8 cases,
          including 3 [(123)I]MIBG-negative metastatic cases. In addition,
          [(123)I]MIBG and SRI detected 2 recurrences. In conclusion, [(123)I]MIBG
          uptake is correlated with the size, epinephrine production, and site of
          PCCs. Its role in bilateral and MEN2A/2B-related PCCs seems limited. In
          cases of recurrent elevation of catecholamines, localization of metastases
          and/or recurrence should be attempted with [(123)I]MIBG scintigraphy. In
          suspicious metastatic PCCs, SRI might be considered to supplement
          [(123)I]MIBG scintigraphy.</description>
    </item> <item>
      <title>Endoscopic retroperitoneal adrenalectomy: Lessons learned from 111 consecutive cases (Article)</title>
      <link>http://repub.eur.nl/res/pub/31848/</link>
      <pubDate>2000-12-13T00:00:00Z</pubDate>
      <description>Objective: To evaluate the effectiveness of endoscopic retroperitoneal adrenalectomy (ERA). Summary Background Data: Minimally invasive adrenalectomy has become the procedure of choice for benign adrenal pathology. Although the adrenal glands are located in the retroperitoneum, most surgeons prefer the transperitoneal laparoscopic approach to adrenal tumors. Methods: Clinical characteristics and outcomes of 111 ERAs from January 1994 to December 1999 were evaluated. Results: Ninety-five patients underwent 111 ERAs (79 unilateral, 16 bilateral). Indications were Cushing syndrome (n = 22), Cushing disease (n = 8), ectopic adrenocorticotropic hormone syndrome (n = 6), Conn's adenoma (n = 25), pheochromocytoma (n = 19), incidentaloma (n = 11), and other (n = 4). Tumor size varied from 0.1 to 8 cm. Median age was 50 years. Unilateral ERA required 114 minutes, with median blood loss of 65 mL. Bilateral ERA lasted 214 minutes, with median blood loss of 121 mL. The conversion rate to open surgery was 4.5%. The complication rate was 11%. Median postoperative hospital stay was 2 days for unilateral ERA and 5 days for bilateral ERA. The death rate was 0.9%. At a median follow-up of 14 months, the recurrence rate of disease was 0.9%. Conclusion: For benign adrenal tumors less than 6 cm, ERA is recommended.</description>
    </item> <item>
      <title>Automated depth-scanning confocal Raman microspectrometer for rapid in vivo determination of water concentration profiles in human skin (Article)</title>
      <link>http://repub.eur.nl/res/pub/10882/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>An automated confocal Raman microspectrometer for rapid measurement of molecular concentration profiles in the skin is described. It permits the successive collection of Raman spectra at a range of depths below the skin surface. The axial resolution of the confocal Raman microspectrometer is 5.1 +/- 0.2 mu m. The setup was applied to determine water concentration profiles of the stratum corneum and to determine changes therein as a result of hydration of the skin.</description>
    </item> <item>
      <title>Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock (Article)</title>
      <link>http://repub.eur.nl/res/pub/9000/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: The systemic hypotension during human sepsis has been ascribed
          to increased production of nitric oxide (NO). Therefore, inhibitors of NO
          synthesis have been used in the treatment of hypotension in patients with
          septic shock. In addition, NO production may inhibit the synthesis and
          vasoconstrictor effects of endothelin-1 (ET-1). In this study, we tested
          whether ET-1 contributed to the vasopressor action of the NO synthase
          inhibitor NG-nitro-L-arginine methyl ester (L-NAME) in patients with
          severe septic shock. METHODS AND RESULTS: Compared with healthy
          volunteers, patients with septic shock had increased plasma levels of
          nitrite/nitrate (37+/-5 [SEM] versus 12+/-5 mmol/L, P&lt;0.01), the stable
          end products of NO metabolism, and ET-1 (45+/-7 versus 3+/-2 pg/mL,
          P&lt;0.001). Plasma ET-1 concentration was not related to plasma
          nitrite/nitrate concentration or blood pressure. Continuous infusion of
          L-NAME (1 mg. kg-1. h-1 IV) for 12 hours increased mean arterial pressure
          by 43+/-5% and systemic vascular resistance by 64+/-10% (both P&lt;0.01). The
          increase in blood pressure and systemic vascular resistance correlated
          positively with the level of ET-1 (both P&lt;0. 005) but not with plasma
          nitrite/nitrate level. L-NAME infusion did not result in significant
          changes in the plasma concentrations of ET-1 or nitrite/nitrate.
          CONCLUSIONS: NO and ET-1 may both play a role in the cardiovascular
          derangements of human sepsis. Although L-NAME does not increase ET-1
          concentration in patients with septic shock, the vasopressor response
          induced by L-NAME depends on the plasma level of ET-1. These findings may
          indicate that inhibitors of NO synthesis unmask a tonic pressor response
          of ET-1 in human septic shock.</description>
    </item> <item>
      <title>Regional ischemia in hypertrophic Langendorff-perfused rat hearts (Article)</title>
      <link>http://repub.eur.nl/res/pub/9175/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Myocardial hypertrophy decreases the muscle mass-to-vascularization ratio,
          thereby changing myocardial perfusion. The effect of these changes on
          myocardial oxygenation in hypertrophic Langendorff-perfused rat hearts was
          measured using epimyocardial NADH videofluorimetry, whereby ischemic
          myocardium displays a high fluorescence intensity. Hypertrophic hearts, in
          contrast to control hearts, developed ischemic areas during
          oxygen-saturated Langendorff perfusion. Reoxygenation of control hearts
          after a hypoxic episode resulted in a swift decrease of fluorescence in a
          heterogeneous pattern of small, evenly dispersed, highly fluorescent
          patches. Identical patterns could be evoked by occluding capillaries with
          microspheres 5.9 micrometer in diameter. Ten seconds after reoxygenation
          there were no more dysoxic areas, whereas reoxygenation in hypertrophic
          hearts showed larger ischemic areas that took significantly longer to
          return to normoxic fluorescence intensities. Hypothesizing that the larger
          areas originate at a vascular level proximal to the capillary network, we
          induced hypoxic patterns by embolizing control hearts with microspheres
          9.8 and 15 micrometer in diameter. The frequency distribution histograms
          of these dysoxic surface areas matched those of hypertrophic hearts and
          differed significantly from those of hearts embolized with 5.9-micrometer
          microspheres. These results suggest the existence of areas in hypertrophic
          Langendorff-perfused hearts with suboptimal vascularization originating at
          the arteriolar and/or arterial level.</description>
    </item> <item>
      <title>Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock (Article)</title>
      <link>http://repub.eur.nl/res/pub/8844/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>STUDY OBJECTIVES: We tested the effects of continuous infusion of
          N(G)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide
          (NO) synthesis, on cardiovascular performance and pulmonary gas exchange
          in patients with hyperdynamic septic shock. DESIGN: Prospective clinical
          study. SETTING: ICU of a university hospital. PATIENTS: Eleven critically
          ill patients with severe refractory septic shock. INTERVENTIONS: Standard
          hemodynamic measurements were made and blood samples taken before, during,
          and after 12 h of continuous infusion of 1 mg/kg/h of L-NAME. MEASUREMENTS
          AND RESULTS: Continuous infusion of L-NAME increased mean arterial
          pressure (MAP) from 65+/-3 (SEM) to 93+/-4 mm Hg and systemic vascular
          resistance (SVR) from 962+/-121 to 1,563+/-173 dyne x s x cm(-5)/m2.
          Parallel to this, cardiac index (CI) decreased from 4.8+/-0.4 to 3.9+/-0.4
          L/min/m2 and myocardial stroke volume (SV) was reduced from 43+/-3 to
          34+/-3 mL/m2. Left ventricular stroke work was increased in the first hour
          of L-NAME infusion from 31+/-3 to 43+/-4 g x m/m2 (all p&lt;0.01 compared
          with baseline). Heart rate, cardiac filling pressures, and right
          ventricular stroke work did not change significantly (p&gt;0.05). L-NAME
          increased the ratio of arterial PO2 to the fraction of inspired O2 from
          167+/-23 to 212+/-27 mm Hg (p&lt;0.05). Venous admixture (QVA/QT) was reduced
          from 19.4+/-2.6% to 14.2+/-2.1% (p&lt;0.05) and oxygen extraction ratio
          increased from 21.1+/-2.4% to 25.3+/-2.7% (p&lt;0.05). Oxygen delivery (DO2)
          was reduced following L-NAME, whereas oxygen uptake and arterial lactate
          and pH were unchanged. CONCLUSIONS: Prolonged inhibition of NO synthesis
          with L-NAME can restore MAP and SVR in patients with severe septic shock.
          Myocardial SV and CI decrease, probably as a result of increased
          afterload, since heart rate and stroke work were not reduced. L-NAME can
          improve pulmonary gas exchange with a concomitant reduction in QVA/QT.
          L-NAME did not promote anaerobe metabolism despite a reduction in DO2.</description>
    </item> <item>
      <title>Constipation as the presenting symptom in de novo multiple endocrine neoplasia type 2B (Article)</title>
      <link>http://repub.eur.nl/res/pub/8889/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>(Semi-)quantitative analysis of reduced nicotinamide adenine dinucleotide fluorescence images of blood-perfused rat heart (Article)</title>
      <link>http://repub.eur.nl/res/pub/8662/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>In vivo analysis of the metabolic state of tissue by means of reduced
      nicotinamide adenine dinucleotide (NADH) fluorimetry is disturbed by
      tissue movements and by hemodynamic and oximetric effects. These factors
      cause changes in the absorption of ultraviolet (UV) excitation light by
      the tissue. Many different methods have been used in the literature to
      compensate measured NADH fluorescence intensities for these effects. In
      this paper we show on theoretical grounds that the ratio of NADH
      fluorescence intensity and UV diffuse reflectance intensity provides a
      (semi-)quantitative measure of tissue NADH concentrations. This result is
      corroborated by experiments with tissue phantoms in which absorption and
      back-scattering properties were varied. Furthermore, we have verified the
      validity of this compensation method in isolated Langendorff-perfused rat
      heart preparations. In this preparation oximetric effects (of blood and
      tissue) are the major determinants of the metabolism-dependent UV diffuse
      reflectance change. Hemodynamic effects accompanying compensatory
      vasodilation are negligible. Movement artifacts were eliminated by
      simultaneously recording fluorescence and reflectance images, using a CCD
      camera with a biprism configuration. The results show that the NADH
      fluorescence/UV reflectance ratio can be used to monitor the mitochondrial
      redox state of the surface of intact blood-perfused myocardium.</description>
    </item> <item>
      <title>The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors (Article)</title>
      <link>http://repub.eur.nl/res/pub/8618/</link>
      <pubDate>1996-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: In the present study, the diagnostic value of somatostatin
          receptor scintigraphy (SRS) was evaluated in the preoperative workup in
          patients with pancreatic duct cancers and islet cell tumors, as well as in
          the follow-up of these patients. METHODS: Twenty-six patients with
          suspected primary pancreatic duct cancers and 48 patients with islet cell
          tumors were studied. The SRS was performed using the radionuclide-labeled
          somatostatin analogue 111In-octreotide. Another group of 12 patients who
          were still alive more than 3 years after pancreaticoduodenectomy for
          pancreatic duct adenocarcinomas also underwent SRS. RESULTS: In 31 (65%)
          of 48 patients, the primary pancreatic islet cell tumor as well as its
          often previously not yet recognized metastases could be visualized. In
          contrast, none of the 26 pancreatic adenocarcinomas or their metastases
          could be seen. In 5 of 12 patients who were alive more than 3 years after
          pancreaticoduodenectomy for pancreatic duct adenocarcinomas, metastatic
          lesions were visualized at SRS. In retrospect, these patients were not
          operated on for adenocarcinomas but for "nonfunctioning" islet cell
          tumors. CONCLUSIONS: The present study supports the concept that SRS has a
          place in the preoperative differential diagnosis of islet cell tumors and
          pancreatic duct cancers as well as in the follow-up, especially in those
          cases in which no tumor histologic analysis was obtained, or the
          pathologic examination of the tumor tissue had not included special
          staining procedures for neuroendocrine characteristics. Our results also
          indicate that the evaluation of the results of investigations on the role
          of surgery or radiation therapy and chemotherapy or both in pancreatic
          duct cancer have to be interpreted with caution, if no histologic analysis
          and staining for neuroendocrine characteristics was performed.</description>
    </item> <item>
      <title>Patient-to-patient spread of a single strain of Corynebacterium striatum causing infections in a surgical intensive care unit (Article)</title>
      <link>http://repub.eur.nl/res/pub/8629/</link>
      <pubDate>1996-01-01T00:00:00Z</pubDate>
      <description>Over a 12-month period, Corynebacterium striatum strains were isolated
          from clinical specimens from 14 patients admitted to a surgical intensive
          care unit. These isolates were identical by morphology and biotype and
          displayed the same antibiogram. Ten isolates were found to be the sole
          possible pathogen. These 10 isolates were from six patients, three of whom
          had signs of infection at the time of positive culture. Further typing was
          performed by random amplification of polymorphic DNA analysis, by which
          all strains were identical and were found to differ to various degrees
          from reference strains and from isolates found in clinical samples from
          other wards. In a case-control study the only independent risk factor for
          acquiring the strain was intubation for longer than 24 h (odds ratio,
          20.09; 95% confidence interval, 2.29 to 176.09). The same strain was
          isolated from surfaces and from air sampled in the direct vicinity of
          infected patients but never from surfaces or air in other places of the
          ward. The strain was not isolated from the ventilators. The strain was
          cultured from the hands of personnel attending to infected patients, but
          no long-term carriers were found among members of the hospital personnel,
          suggesting transient carriage only. We conclude that C. striatum can cause
          serious nosocomial infections in surgical intensive care unit patients and
          may spread from patient to patient via the hands of attending personnel.</description>
    </item> <item>
      <title>Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis (Article)</title>
      <link>http://repub.eur.nl/res/pub/8538/</link>
      <pubDate>1995-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: A randomized, controlled, multicenter trial was undertaken in
          102 patients with objective evidence of severe acute pancreatitis to
          evaluate whether selective decontamination reduces mortality. SUMMARY
          BACKGROUND DATA: Secondary pancreatic infection is the major cause of
          death in patients with acute necrotizing pancreatitis. Controlled clinical
          trials to study the effect of selective decontamination in such patients
          are not available. METHODS: Between April 22, 1990 and April 19, 1993, 102
          patients with severe acute pancreatitis were admitted to 16 participating
          hospitals. Patients were entered into the study if severe acute
          pancreatitis was indicated, on admission, by multiple laboratory criteria
          (Imrie score &gt; or = 3) and/or computed tomography criteria (Balthazar
          grade D or E). Patients were randomly assigned to receive standard
          treatment (control group) or standard treatment plus selective
          decontamination (norfloxacin, colistin, amphotericin; selective
          decontamination group). All patients received full supportive treatment,
          and surveillance cultures were taken in both groups. RESULTS: Fifty
          patients were assigned to the selective decontamination group and 52 were
          assigned to the control group. There were 18 deaths in the control group
          (35%), compared with 11 deaths (22%) in the selective decontamination
          group (adjusted for Imrie score and Balthazar grade: p = 0.048). This
          difference was mainly caused by a reduction of late mortality (&gt; 2 weeks)
          due to significant reduction of gram-negative pancreatic infection (p =
          0.003). The average number of laparotomies per patient was reduced in
          patients treated with selective decontamination (p &lt; 0.05). Failure of
          selective decontamination to prevent secondary gram-negative pancreatic
          infection with subsequent death was seen in only three patients (6%) and
          transient gram-negative pancreatic infection was seen in one (2%). In both
          groups of patients, all gram-negative aerobic pancreatic infection was
          preceded by colonization of the digestive tract by the same bacteria.
          CONCLUSION: Reduction of gram-negative colonization of the digestive
          tract, preventing subsequent pancreatic infection by means of selective
          decontamination, significantly reduces morbidity and mortality in patients
          with severe acute necrotizing pancreatitis.</description>
    </item>
  </channel>
</rss>